QingSong Health (02661) Sets 23 Mar 2026 Board Meeting to Approve FY 2025 Results and Discuss Final Dividend

Bulletin Express
03/10

QingSong Health Corporation (Stock Code: 02661) has scheduled a board meeting for 23 March 2026. The agenda includes:

• Approval of the consolidated annual results for the financial year ended 31 December 2025.

• Consideration of a recommendation for a final dividend, if any.

The meeting will be chaired by Ms. Yang Yin, who serves as Chairlady, Executive Director and Chief Executive Officer. The Board currently consists of eight members: Executive Directors Ms. Yang Yin and Ms. Wang Jing; Non-executive Directors Mr. Zhao Yuping, Mr. Zheng Kaihuan and Mr. Wu Bin; and Independent Non-executive Directors Dr. Wang Xiaoyan, Mr. Chow Yiu Ming and Mr. Bai Kun.

The company will publish its FY 2025 results and any dividend proposal following the meeting’s conclusion.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10